Top Abstract Purchase Related
Home
>
Node
>
Subnode

The European pharmacovigilance: regulatory aspects

Dhanani, A.; Castot, A.

Presse Medicale 29(2): 107-110

2000

ISSN/ISBN: 0755-4982
PMID: 10682041
Document Number: 523393
ESTABLISHMENT: The European pharmacovigilance system has been operating since 1995 when the European Agency for the Evaluation of Medicinal Products as well as two new European registration procedures were established. This system is very similar to the French organization and is based on a decentralized collection and validation of safety data by member states and a centralized evaluation and decision making process at the European Agency for the Evaluation of Medicinal Products performed by the Committee for Proprietary Medicinal Products (CPMP) and its Pharmacovigilance Working Party. A EUROPEAN SYSTEM: In light of the experience gained, the European pharmacovigilance system moved to an interactive system which relies on a close cooperation between member states ensuring the common evaluation and management of safety concerns.

Document emailed within 1 workday
Secure & encrypted payments

Monteagudo, J.L. 1996: Data exchange in the European pharmacovigilance Studies in Health Technology and Informatics 28: 69-77
Xie, Y-Ming.; Tian, F. 2013: Interpretation of Guidelines on Good Pharmacovigilance Practices for European Union Zhongguo Zhong Yao Za Zhi 38(18): 2963-2968
Pierfitte, C.; Hanesse, B.; Royer, R.J. 1995: Opinion survey of European pharmacovigilance: opinion of French practitioners Therapie 50(2): 171-172
Brooks, P. 1998: Standards in the European regulatory process Biomedical Instrumentation and Technology 32(6): 615-618
Abadie, E.; Souetre, E. 1993: Economic aspects of pharmacovigilance in the pharmaceutical industry Therapie 48(2): 125-127
2002: Opinion on ethical aspects of patenting inventions involving human stem cells. The European Group on Ethics in Science and New Technologies to the European Commission. 7 May 2002 Revista de Derecho y Genoma Humano 2002(16): 266-271
Pastoret, P.P.; Mackay, D. 2003: Regulatory considerations for emergency use of vaccines in the European Union Developments in Biologicals 114: 53-58
Calcagnini, G.; Censi, F.; Bartolini, P. 2007: Electromagnetic immunity of medical devices: the European regulatory framework Annali Dell'istituto Superiore di Sanita 43(3): 268-276
Robertson, J.S.; Cichutek, K. 2000: European Union guidance on the quality, safety and efficacy of DNA vaccines and regulatory requirements Developments in Biologicals 104: 53-56
Crijns, I.; Straus, S.; Luteijn, M.; Gispen-de Wied, C.; Raine, J.; de Jong-van den Berg, L. 2012: Implementation of the harmonized EU isotretinoin Pregnancy Prevention Programme: a questionnaire survey among European regulatory agencies Drug Safety 35(1): 27-32
Celis, P.; Silvester, G. 2004: European Regulatory guidance on virus safety of recombinant proteins, monoclonal antibodies and plasma derived medicinal products Developments in Biologicals 118: 3-10
Pogosova, N.; Saner, H.; Pedersen, S.S.; Cupples, M.E.; Mc Gee, H.; Hofer, S.; Doyle, F.; Schmid, J.-P.; VON Kanel On Behalf Of The Cardiac Rehabilitation Section Of The European Association Of Cardiovascular Prevention And Rehabilitation Of The European Society Of Cardiology, R. 2015: Psychosocial Aspects in Cardiac Rehabilitation: From Theory to Practice. A Position Paper From the Cardiac Rehabilitation Section of The European Association of Cardiovascular Prevention and Rehabilitation of the European Society of Cardiology Kardiologiia 55(10): 96-108
Weber, J.C.W. 1992: Regulatory aspects of vaccine development Ada, G L And P D Griffin (Ed ) Scientific Basis Of Fertility Regulation, Vol 5 Vaccines For Fertility Regulation: The Assessment Of Their Safety And Efficacy; Symposium, Geneva, Switzerland, June 12-16, 1989 Xviii+305p Cambridge University Press: Cambridge, England, Uk; New York, New York, Usa Illus 185-200
Legay, C.; Ternaux, J.P. 1982: Regulatory aspects of 5-HT biosynthesis in the intestinal tract of the rat Scandinavian Journal of Gastroenterology. Suppl 71: 167
Lyda, J.C. 1995: Regulatory aspects of isolation/barrier technology PDA Journal of Pharmaceutical Science and Technology 49(6): 300-304
Pommerenke, F.; Hegmann, K.; Hartenbaum, N.P. 1998: DOT examinations: practical aspects and regulatory review American Family Physician 58(2): 415-426
Dangoumau, J. 1992: Allergens: regulatory aspects and national standards in France Arbeiten aus dem Paul-Ehrlich-Institut Zu Frankfurt A.M 1992(85): 141-146
Indulski, J.; Baranski, B. 1986: Scientific and regulatory aspects of occupational cancer prevention in Poland La Medicina del Lavoro 77(4): 330-337
Adekunle, A.O.; Babarinsa, I.A.; Akinyemi, Z.; Okediran, A.Y. 2001: Legal and regulatory aspects of prescribing and marketing emergency contraception in Nigeria African Journal of Medicine and Medical Sciences 30(1-2): 143-150
Sciaky, N.; Razin, A.; Gazit, B.; Mager, J. 1973: Regulatory aspects of the synthesis of 5-phosphoribosyl-1-pyrophosphate in human red blood cells Advances in Experimental Medicine and Biology 41: 87-92